RK Capital - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RK Capital ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$13,346,496
-3.0%
300,800
+4.4%
3.16%
+7.0%
Q2 2023$13,753,894
+4.2%
288,100
-14.1%
2.95%
+1.8%
Q1 2023$13,197,990
+27.5%
335,400
-8.4%
2.90%
+18.2%
Q4 2022$10,354,140
-2.1%
366,000
+4.0%
2.45%
-9.5%
Q3 2022$10,576,000
+3.9%
351,841
+17.4%
2.71%
+13.3%
Q2 2022$10,175,000
+6.4%
299,800
+40.6%
2.39%
+27.6%
Q1 2022$9,560,000
+42.1%
213,200
+46.4%
1.88%
+53.5%
Q4 2021$6,728,000
+36.0%
145,600
-1.2%
1.22%
+30.6%
Q3 2021$4,948,000
-20.0%
147,319
-30.0%
0.94%
-19.5%
Q2 2021$6,188,000
+3.3%
210,400
-9.5%
1.16%
-2.6%
Q1 2021$5,992,000
+10.6%
232,500
-2.1%
1.19%
-0.3%
Q4 2020$5,417,000
+16.6%
237,600
+9.4%
1.20%
-9.0%
Q3 2020$4,644,000
-17.8%
217,200
-10.8%
1.32%
-20.3%
Q2 2020$5,652,000
+25.3%
243,500
+15.2%
1.65%
-18.6%
Q1 2020$4,512,000
-13.4%
211,325
-5.2%
2.03%
+4.0%
Q4 2019$5,212,000
+7.5%
222,914
-3.4%
1.95%
+10.0%
Q3 2019$4,850,000
+22.5%
230,729
+19.2%
1.77%
+44.8%
Q2 2019$3,959,000
+8.5%
193,574
+49.1%
1.22%
+16.6%
Q1 2019$3,648,000129,8611.05%
Other shareholders
IRADIMED CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders